Supn stock earnings date
Supernus Pharmaceuticals Inc (SUPN) Q4 2019 Earnings Call ... SUPN earnings call for the period ending December 31, 2019. the FDA accepted for review our NDA with a PDUFA target action date of November 8, 2020. Stock Advisor launched in February of Supernus Pharmaceuticals Stock Quote: SUPN Stock News ... Nov 08, 2019 · Supernus Pharmaceuticals (SUPN) Q4 Earnings Beat Estimates Supernus (SUPN) delivered earnings and revenue surprises of 8.77% and -6.36%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock? Supernus Pharmaceuticals Inc (SUPN) Q3 2019 Earnings Call ...
SUPN earnings call for the period ending December 31, 2019. the FDA accepted for review our NDA with a PDUFA target action date of November 8, 2020. Stock Advisor launched in February of
SUPN - Supernus Pharm Stock Price - Barchart.com Next Earnings Date: The next reported earnings date. Annual Dividend & Yield : The indicated annual dividend rate and yield, calculated from the latest dividend. The dividend rate is the portion of a company's profit paid to shareholders, quoted as the dollar … SUPN - Supernus Pharmaceuticals, Inc. Summary, Stock Quote ... Jan 01, 2010 · Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance SUPN Stock Rating and Data | Supernus Pharmaceuticals ... SUPN stock rating and analysis - Supernus Pharmaceuticals : a summary of key financial strength and profitability metrics. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial SUPN - Supernus Pharm Stock Earnings Estimates - Barchart.com
Earnings Date Start Date : Current Date + 15 Days; Earnings Date End Date : Current Date + 30 Days; Predicted Move (Next Day) Min : 5%; Options Type: Weekly or Monthly if that lines up with the two to three-week lead-time for entering the trade; Strategy Guideline: Buy a Straddle at or close to the money two to three weeks pre-EA.
In depth view into SUPN (Supernus Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Supernus Pharmaceuticals Inc. - NASDAQ:SUPN - Stock Quote ... Explore commentary on Supernus Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about SUPN. TheStreet Ratings updates stock ratings daily. Year-to-date mutual fund SUPN Supernus Pharmaceuticals, Inc. — Stock Price and ... Real-time trade and investing ideas on Supernus Pharmaceuticals, Inc. SUPN from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.
valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on SUPN. Stocks by Morningstar Classification
May 09, 2017 · SUPN had returned +26.34% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period. More Info About Supernus Pharmaceuticals, Inc. (SUPN) Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous SUPN Stock News - Fidelity Mar 27, 2020 · Supernus Pharmaceuticals, Inc. (SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that the Company's management will present an overview and update, as well as host investor meetings, at the 40th Annual Cowen Health Care Conference. SUPN Supernus Pharmaceuticals, Inc. Stock Quote
SUPN Earnings Date, Forecast and Report (Supernus ...
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. SUPN's fiscal year ends in December. Market Supernus Pharmaceuticals, Inc. (SUPN) Stock Historical ... Discover historical prices for SUPN stock on Yahoo Finance. View daily, weekly or monthly format back to when Supernus Pharmaceuticals, Inc. stock was issued.
Nov 5, 2019 Supernus Pharmaceuticals (SUPN) came out with quarterly earnings of This quarterly report represents an earnings surprise of -8.47%.